NCT06540066
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06540066
Title A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors BeiGene
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA

Facility Status City State Zip Country Details
Usc Norris Comprehensive Cancer Center (Nccc) RECRUITING Los Angeles California 90089-1019 United States Details
Washington University in St Louis RECRUITING St Louis Missouri 63110-1010 United States Details
Hackensack University Medical Center RECRUITING Hackensack New Jersey 07601-1915 United States Details
Next Oncology RECRUITING Austin Texas 78758 United States Details
Md Anderson Cancer Center RECRUITING Houston Texas 77030-3907 United States Details
Cancer Hospital Chinese Academy of Medical Sciences ACTIVE_NOT_RECRUITING Beijing Beijing Municipality 100021 China Details
Beijing Cancer Hospital RECRUITING Beijing Beijing Municipality 100142 China Details
Affiliated Zhongshan Hospital of Fudan University RECRUITING Shanghai Shanghai Municipality 200032 China Details
Fondazione Irccs Istituto Nazionale Dei Tumori RECRUITING Milan 20133 Italy Details
Istituto Europeo Di Oncologia RECRUITING Milan 20141 Italy Details
Fondazione Policlinico Universitario Agostino Gemelli RECRUITING Roma 00168 Italy Details
Istituto Clinico Humanitas RECRUITING Rozzano 20089 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field